Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-10-04
1995-03-28
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544329, C07D40114, A61K 31505
Patent
active
054017440
ABSTRACT:
The hemi-hydrate form of the cerebral function enhancing agent 1-[[1-[2-(trifluoromethyl)-4-pyrimidinyl]-4-piperidinyl]-methyl-2-pyrrolid inone, or BMY-21502 as it is more commonly designated, is an improved form of drug substance having equivalent biopharmaceutical properties compared to the known anhydrous form but providing cost, safety and ecological advantages in manufacture over the known anhydrous form.
REFERENCES:
patent: 4826843 (1989-05-01), Mattson et al.
patent: 4963678 (1990-10-01), Madding et al.
patent: 5098904 (1992-03-01), Mattson et al.
Bristol--Myers Squibb Company
Ford John M.
Ryan Richard P.
LandOfFree
Useful hemi-hydrate form of a cerebral function enhancing agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Useful hemi-hydrate form of a cerebral function enhancing agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Useful hemi-hydrate form of a cerebral function enhancing agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2250715